NCT06825819View on ClinicalTrials.gov

Dysbiosis & Long COVID

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

January 21, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
COVID-19
Interventions
BIOLOGICAL

Subjects with and without Long COVID

To collect biospecimens (matched stool \& blood) samples from 400 people with and without long COVID (200 participants/group) to understand how COVID-induced dysbiosis impacts symptom severity, immune suppression, and gut barrier dysfunction both ex vivo and in vitro.

Trial Locations (1)

60637

RECRUITING

The University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER